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FOLLOW-UP OF THE HUMORAL RESPONSE OF PATIENTS WITH LEISHMANIASIS FROM THE
WESTERN AMAZON REGION, BEFORE AND AFTER TREATMENT
Indirect immunofluorescence (IIF-IgG) and enzyme immunoassay
(ELISA-IgG) were used to assess the humoral response of patients with
American tegumental leishmaniasis (ATL) in the cutaneous (CL),
mucocutaneous (MCL) or mucosal (ML) forms and with visceral
leishmaniasis (VL), originating from the state of Amazonas and from
other states of the Western Amazon Region and attended at the Tropical
Medicine Foundation (TMF). The importance of the results for the
diagnosis and follow-up of the patients was assessed before and after
treatment. The results were compared to the clinical data and to at least
one technique of parasitological or immunological diagnosis, direct
detection of parasites in the lesion, histopathological examination, parasite
culture, inoculation of hamsters, and Montenegro skin test. For the IIF-
IgG test we analyzed the performance of the following antigens: M2682
(MHOM/BR/74) reference strain of Leishmania (Leishmania) chagasi
(from Pará); M320446 (MHOM/BR/89) also L. (L.) chagasi (from
Roraima); PH8 (IFLA/BR/67) reference strain L. (L.) amazonensis,
Lainson & Shaw, 1972 and M81889 (MHOM/BR/89) also L. (L.)
amazonensis (from Amazonas) and compared them to the antigen
distributed by the Ministry of Health /Brazil (MH/BR), used in the present
study as the control standard for the search of antibodies of the IgG
class. The antigens used for ELISA were PH8 and M81889. The 81
patients whose sera were analyzed were seen at FMT. The cut-off point
for the IIF test was 1:20 for all antigens used and 1:40 for ELISA. The
correlation of the frequency distribution of the antibody titers in the IIF
test in the presence of the cited strains before and after treatment was
calculated by nonparametric data analysis using the Sign Test. The indices
of diagnostic performance (IDD), of precision and sensitivity (S) and
specificity (Sp) were determined and the positive (PPV) and negative
(NPV) predictive values were measured. With the IIF test, the CL form
showed S = 77.8% to 95.2%; Sp = 3.8 to 7.1%. PPV was 21.9 to 60.6%
and NPV 33.3% to 50.0%. For both the CML and VL forms, the IIF test
showed S = 100%, Sp = 5.6% to 12.5%, PPV = 18.2 to 33.3%, and NPV
= 100%. We observed that the data were lower for CL than for the other
forms of the disease, in contrast to ELISA, in which the indices were
higher for CL than for CML and VL. Thus, for CL, S = 100.0%, Sp=
7.7%, PPV = 45.5%, and NPV = 50.0%. For both the CML and VL
forms, ELISA showed S = 90.9%, Sp = 7.7%, PPV = 45.5%, and NPV
= 50.0%. The strains whose results most closely resembled the MH/BR
standard were PH8 and M81889. On the basis of the IDD obtained, we
also conclude that when the IIF test was used the PH8 and M81889
strains reproduced results very close to those obtained with the strain
recommended by the MH/BR and could be routinely used in laboratories
working with leishmaniasis.
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